PharmaShots | Incisive News in 3 Shots

Subscribe Now

Viridian Therapeutics

Viridian Therapeutics Reports Topline Data from P-III (THRIVE-2) Study of Veligrotug to Treat Chronic Thyroid Eye Disease

Viridian Therapeutics Reports Topline Data from P-III (THRIVE-2) Study of Veligrotug to Treat Chronic Thyroid Eye Disease

December 17, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us